ImmuneScope is a cutting-edge biotech start-up specializing in computational and immune insights, aiming to revolutionize the field of cell therapy and enhance patient outcomes. We are based in Dallas, Michigan, and are driven by our mission to increase cell and immunotherapy compatibility, leading to successful transplants and therapies.
Our team is devoted to delivering a groundbreaking product and technology to market that addresses the need for improved immunotherapy outcomes. This technology will optimize donor selection for allogeneic hematopoietic stem cell transplants, increasing the response rate that comes with the current upfront but increasingly incompatible selection process. Additionally, this technology will assist biotech companies in developing and delivering the most robust "off-the-shelf" adoptive cell therapies.
The team of experts at ImmuneScope is determined to bring the most innovative digital immune diagnostics and services for unmet medical needs to live. Our goal is to ensure everyone in need of specialized treatment receives the best possible outcome, and as such, they are committed to using their technology to achieve these outcomes.
Passionate and established, we strive to make an impact by improving immune system compatibility and making cell transplants and therapies more successful. If you’re interested in partnering with ImmuneScope or if you’re inspired by our mission and want to learn more, we would love to hear from you at
[email protected]. Alternatively, if you’re feeling generous today, you can always donate to the investigations and the development of this technology.